Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Approaches for studying radiation-induced leukemia

D F Gluzman1

  • 1R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, Ukraine.

Stem Cells (Dayton, Ohio)
|January 1, 1997
PubMed
Summary

Early Chernobyl studies found no increase in blood cancers. However, long-term research on radiation-induced leukemias and lymphomas is crucial, considering delayed effects observed in atomic bomb survivors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RAPID LOW-COST DETECTION OF TYPE 2CALR MUTATION BY ALLELE-SPECIFIC RT-PCR FOR DIAGNOSIS OF MYELOPROLIFERATIVE NEOPLASMS.

Experimental oncology·2022
Same author

Long-term exposure to low doses of ionizing radiation and COVID-19 pandemic: oncohematological aspects.

Experimental oncology·2021
Same author

Immunodeficiency-associated lymphoproliferative disorders and lymphoid neoplasms in post-COVID-19 pandemic era.

Experimental oncology·2021
Same author

Aberrant expression of placental-like alkaline phosphatase in chronic myeloid leukemia cells in vitro and its modulation by vitamin E.

Experimental oncology·2020
Same author

Immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia.

Experimental oncology·2019
Same author

Vitamin Е activates expression of С/EBP alpha transcription factor and G-CSF receptor in leukemic K562 cells.

Experimental oncology·2018

Area of Science:

  • Hematology
  • Oncology
  • Radiation Epidemiology

Background:

  • The International Programme on the Health Effects of the Chernobyl Accident (IPHECA) Haematology Pilot Project (1991-1995) found no immediate increase in hematopoietic and lymphoid malignancies post-Chernobyl.
  • Atomic bomb survivor studies suggest a latency period of over 10 years for peak radiation-induced cancer incidence.

Purpose of the Study:

  • To emphasize the necessity of long-term studies for hemoblastoses and myelodysplastic syndromes potentially induced by ionizing radiation.
  • To outline a comprehensive research strategy for investigating radiation-related leukemias and lymphomas.

Main Methods:

  • Epidemiological design for population-based studies.
  • Advanced diagnostic techniques including cytomorphology, immunocytochemistry, and cytogenetics.
  • Molecular analyses focusing on gene mutations, apoptosis, G1 delay, oncogene expression, and multidrug resistance genes.
  • Assessment of cell-cell signaling within the bone marrow microenvironment.

Main Results:

  • Initial IPHECA findings indicated no acute rise in blood and lymphoid cancers after Chernobyl.
  • A critical need for ongoing, long-term surveillance is highlighted due to potential delayed radiation effects.

Conclusions:

  • While immediate increases in malignant diseases of hematopoietic and lymphoid tissues were not observed post-Chernobyl, long-term monitoring is essential.
  • A multidisciplinary approach combining epidemiology, advanced diagnostics, and molecular biology is required to fully understand radiation-induced hemoblastoses and myelodysplastic syndromes.

Related Experiment Videos